Kuks JBM - Search Results

1

The extremity function index (EFI), a disability severity measure for neuromuscular diseases: psychometric evaluation.

Bos I, Wynia K, Drost G, Almansa J, Kuks JBM. Bos I, et al. Among authors: kuks jbm. Disabil Rehabil. 2018 Jun;40(13):1561-1568. doi: 10.1080/09638288.2017.1300690. Epub 2017 Mar 14. Disabil Rehabil. 2018. PMID: 28291950

2

The prevalence and severity of disease-related disabilities and their impact on quality of life in neuromuscular diseases.

Bos I, Wynia K, Almansa J, Drost G, Kremer B, Kuks J. Bos I, et al. Disabil Rehabil. 2019 Jul;41(14):1676-1681. doi: 10.1080/09638288.2018.1446188. Epub 2018 Mar 8. Disabil Rehabil. 2019. PMID: 29514523

3

Validation of the ICF core set for neuromuscular diseases.

Bos I, Stallinga HA, Middel B, Kuks JB, Wynia K. Bos I, et al. Eur J Phys Rehabil Med. 2013 Apr;49(2):179-87. Epub 2012 Nov 21. Eur J Phys Rehabil Med. 2013. PMID: 23172408 Free article.

4

Stability and relative validity of the Neuromuscular Disease Impact Profile (NMDIP).

Bos I, Kuks JBM, Almansa J, Kremer HPH, Wynia K. Bos I, et al. Among authors: kuks jbm. BMC Neurol. 2017 May 11;17(1):87. doi: 10.1186/s12883-017-0866-6. BMC Neurol. 2017. PMID: 28490360 Free PMC article.

5

Development and testing psychometric properties of an ICF-based health measure: The Neuromuscular Disease Impact Profile.

Bos I, Kuks JB, Wynia K. Bos I, et al. J Rehabil Med. 2015 May;47(5):445-53. doi: 10.2340/16501977-1938. J Rehabil Med. 2015. PMID: 25679115 Free article.

6

Vibration threshold in non-diabetic subjects.

Nolte S, van Londen M, Elting JWJ, de Greef BTA, Kuks JBM, Faber CG, Nolte IM, Groen RJM, Bakker SJL, Groothof D, Lesman-Leegte I, Berger SP, Drost G. Nolte S, et al. Among authors: kuks jbm. PLoS One. 2020 Oct 7;15(10):e0237733. doi: 10.1371/journal.pone.0237733. eCollection 2020. PLoS One. 2020. PMID: 33027294 Free PMC article.

7

In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia.

Trip J, Drost G, Verbove DJ, van der Kooi AJ, Kuks JB, Notermans NC, Verschuuren JJ, de Visser M, van Engelen BG, Faber CG, Ginjaar IB. Trip J, et al. Eur J Hum Genet. 2008 Aug;16(8):921-9. doi: 10.1038/ejhg.2008.39. Epub 2008 Mar 12. Eur J Hum Genet. 2008. PMID: 18337730

8

Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.

Louwsma J, Brunger AF, Bijzet J, Kroesen BJ, Roeloffzen WWH, Bischof A, Kuhle J, Drost G, Lange F, Kuks JBM, Gans ROB, Hazenberg BPC, Nienhuis HLA. Louwsma J, et al. Among authors: kuks jbm. Amyloid. 2021 Mar;28(1):50-55. doi: 10.1080/13506129.2020.1815696. Epub 2020 Sep 4. Amyloid. 2021. PMID: 32883119

9

The epidemiology of neuromuscular disorders: Age at onset and gender in the Netherlands.

Deenen JC, van Doorn PA, Faber CG, van der Kooi AJ, Kuks JB, Notermans NC, Visser LH, Horlings CG, Verschuuren JJ, Verbeek AL, van Engelen BG. Deenen JC, et al. Neuromuscul Disord. 2016 Jul;26(7):447-52. doi: 10.1016/j.nmd.2016.04.011. Epub 2016 Apr 21. Neuromuscul Disord. 2016. PMID: 27212207

10

Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.

Lipka AF, Boldingh MI, van Zwet EW, Schreurs MWJ, Kuks JBM, Tallaksen CM, Titulaer MJ, Verschuuren JJGM. Lipka AF, et al. Among authors: kuks jbm. Neurology. 2020 Feb 4;94(5):e511-e520. doi: 10.1212/WNL.0000000000008747. Epub 2019 Dec 12. Neurology. 2020. PMID: 31831596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page